These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17286585)
1. The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activity. Gillardon F; Kloss A; Berg M; Neumann M; Mechtler K; Hengerer B; Dahlmann B J Neurochem; 2007 Jun; 101(6):1483-90. PubMed ID: 17286585 [TBL] [Abstract][Full Text] [Related]
2. Regulation of murine cardiac 20S proteasomes: role of associating partners. Zong C; Gomes AV; Drews O; Li X; Young GW; Berhane B; Qiao X; French SW; Bardag-Gorce F; Ping P Circ Res; 2006 Aug; 99(4):372-80. PubMed ID: 16857963 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406 [TBL] [Abstract][Full Text] [Related]
4. Mapping the murine cardiac 26S proteasome complexes. Gomes AV; Zong C; Edmondson RD; Li X; Stefani E; Zhang J; Jones RC; Thyparambil S; Wang GW; Qiao X; Bardag-Gorce F; Ping P Circ Res; 2006 Aug; 99(4):362-71. PubMed ID: 16857966 [TBL] [Abstract][Full Text] [Related]
5. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Blandini F; Sinforiani E; Pacchetti C; Samuele A; Bazzini E; Zangaglia R; Nappi G; Martignoni E Neurology; 2006 Feb; 66(4):529-34. PubMed ID: 16505307 [TBL] [Abstract][Full Text] [Related]
6. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes. Cecarini V; Bonfili L; Amici M; Angeletti M; Keller JN; Eleuteri AM Brain Res; 2008 May; 1209():8-18. PubMed ID: 18400214 [TBL] [Abstract][Full Text] [Related]
7. Identification of alpha-type subunits of the Xenopus 20S proteasome and analysis of their changes during the meiotic cell cycle. Wakata Y; Tokumoto M; Horiguchi R; Ishikawa K; Nagahama Y; Tokumoto T BMC Biochem; 2004 Dec; 5(1):18. PubMed ID: 15603592 [TBL] [Abstract][Full Text] [Related]
8. Co- and post-translational modifications of the 26S proteasome in yeast. Kikuchi J; Iwafune Y; Akiyama T; Okayama A; Nakamura H; Arakawa N; Kimura Y; Hirano H Proteomics; 2010 Aug; 10(15):2769-79. PubMed ID: 20486117 [TBL] [Abstract][Full Text] [Related]
9. Toward a full characterization of the human 20S proteasome subunits and their isoforms by a combination of proteomic approaches. Uttenweiler-Joseph S; Claverol S; Sylvius L; Bousquet-Dubouch MP; Burlet-Schiltz O; Monsarrat B Methods Mol Biol; 2008; 484():111-30. PubMed ID: 18592176 [TBL] [Abstract][Full Text] [Related]
10. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders. Schmitt HP Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788 [TBL] [Abstract][Full Text] [Related]
11. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222 [TBL] [Abstract][Full Text] [Related]
12. Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cells. Ducoux-Petit M; Uttenweiler-Joseph S; Brichory F; Bousquet-Dubouch MP; Burlet-Schiltz O; Haeuw JF; Monsarrat B J Proteome Res; 2008 Jul; 7(7):2852-9. PubMed ID: 18510353 [TBL] [Abstract][Full Text] [Related]
13. Quantitative proteome analysis of the 20S proteasome of apoptotic Jurkat T cells. Schmidt F; Dahlmann B; Hustoft HK; Koehler CJ; Strozynski M; Kloss A; Zimny-Arndt U; Jungblut PR; Thiede B Amino Acids; 2011 Jul; 41(2):351-61. PubMed ID: 20364280 [TBL] [Abstract][Full Text] [Related]
14. Purification and proteomic analysis of 20S proteasomes from human cells. Bousquet-Dubouch MP; Uttenweiler-Joseph S; Ducoux-Petit M; Matondo M; Monsarrat B; Burlet-Schiltz O Methods Mol Biol; 2008; 432():301-20. PubMed ID: 18370027 [TBL] [Abstract][Full Text] [Related]
15. Oxidative inactivation of the proteasome in Alzheimer's disease. Cecarini V; Ding Q; Keller JN Free Radic Res; 2007 Jun; 41(6):673-80. PubMed ID: 17516240 [TBL] [Abstract][Full Text] [Related]
16. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients. Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572 [TBL] [Abstract][Full Text] [Related]
17. A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity. Froment C; Uttenweiler-Joseph S; Bousquet-Dubouch MP; Matondo M; Borges JP; Esmenjaud C; Lacroix C; Monsarrat B; Burlet-Schiltz O Proteomics; 2005 Jun; 5(9):2351-63. PubMed ID: 15887188 [TBL] [Abstract][Full Text] [Related]
18. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses. Zouambia M; Fischer DF; Hobo B; De Vos RA; Hol EM; Varndell IM; Sheppard PW; Van Leeuwen FW Proteomics; 2008 Mar; 8(6):1221-36. PubMed ID: 18283660 [TBL] [Abstract][Full Text] [Related]
19. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Mishto M; Bellavista E; Santoro A; Stolzing A; Ligorio C; Nacmias B; Spazzafumo L; Chiappelli M; Licastro F; Sorbi S; Pession A; Ohm T; Grune T; Franceschi C Neurobiol Aging; 2006 Jan; 27(1):54-66. PubMed ID: 16298241 [TBL] [Abstract][Full Text] [Related]
20. Proteasome and photoaging: the effects of UV irradiation. Bulteau AL; Moreau M; Nizard C; Friguet B Ann N Y Acad Sci; 2007 Apr; 1100():280-90. PubMed ID: 17460189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]